# The Lancet

Source: https://nuclide.cc/journals/lancet/  
Nuclide record `lancet` (Journal). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)"; commercial use needs a licence.

## TL;DR

The Lancet is Britain's leading general medical journal and the other main home of practice-changing cancer trials, with a stronger global-health and policy voice than NEJM.

## Summary

The Lancet appears weekly and publishes practice-changing oncology phase 3 trials (CheckMate 649, KEYNOTE-048, CARTITUDE-1, TRANSFORM), the Global Burden of Disease series, and Lancet Commissions that shape cancer policy. Elsevier hybrid model: subscription with an open-access option; abstracts free. Known for editorial campaigning on health inequality and for the HPV-vaccination and cancer-survival population studies that appear in this corpus.

## Fields

- Kind: Journal
- Last checked: 2026-09-09
- Also known as: Lancet
- Publisher: Elsevier
- Scope: general medicine
- Access: hybrid

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/The_Lancet
- Oncology collection: https://www.thelancet.com/clinical/diseases/cancer

## Connected records

- key papers: [NETTER-2: lutetium-177 dotatate as first treatment for higher-grade gastroenteropancreatic neuroendocrine tumours](https://nuclide.cc/key-papers/paper-netter-2-lancet-2024/), [proPSMA: PSMA PET-CT versus conventional imaging for staging high-risk prostate cancer](https://nuclide.cc/key-papers/paper-propsma-hofman-lancet-2020/)

---
JSON: https://nuclide.cc/api/v1/entities/lancet.json